Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents are scarce. We report preliminary results of an Italian multicentre study comprising 168 laboratory-confirmed paediatric cases (median: 2.3 years, range: 1 day–17.7 years, 55.9% males), of which 67.9% were hospitalised and 19.6% had comorbidities. Fever was the most common symptom, gastrointestinal manifestations were frequent; two children required intensive care, five had seizures, 49 received experimental treatments and all recovered.
All Keywords
【저자키워드】 COVID-19, Hydroxychloroquine, Pneumonia, SARS-COV-2 infection, children, 【초록키워드】 Treatment, SARS-CoV-2, coronavirus, intensive care, Comorbidities, Symptom, multicentre, manifestation, Seizures, acute respiratory syndrome, laboratory-confirmed, hospitalised, FIVE, Italian, feature, males, required, 【제목키워드】 Preliminary data, Italian study,
【저자키워드】 COVID-19, Hydroxychloroquine, Pneumonia, SARS-COV-2 infection, children, 【초록키워드】 Treatment, SARS-CoV-2, coronavirus, intensive care, Comorbidities, Symptom, multicentre, manifestation, Seizures, acute respiratory syndrome, laboratory-confirmed, hospitalised, FIVE, Italian, feature, males, required, 【제목키워드】 Preliminary data, Italian study,